Recent Price Movement and Market Context
On 8 December 2025, Ambalal Sarabhai Enterprises recorded its lowest price in the past year at Rs.26.51. This level represents a substantial drop from its 52-week high of Rs.68, reflecting a decline of over 60% within the period. The stock has been on a downward trajectory for the last two consecutive days, with a cumulative return of -1.22% during this short span. Today’s performance also showed a day change of -1.26%, underperforming its Pharmaceuticals & Biotechnology sector by 0.47%.
The broader market, represented by the Sensex, opened flat but later declined by 222.57 points, closing at 85,402.27, down 0.36%. Despite this, the Sensex remains close to its 52-week high, trading just 0.89% below the peak of 86,159.02. The index continues to trade above its 50-day moving average, which itself is positioned above the 200-day moving average, indicating a generally bullish trend for the market overall.
Technical Indicators and Moving Averages
Ambalal Sarabhai Enterprises is currently trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This widespread weakness across short, medium, and long-term technical indicators suggests persistent downward pressure on the stock price. Such positioning often signals a cautious market sentiment towards the company’s near-term prospects.
Our current monthly pick, this Mid Cap from Automobile Two & Three Wheelers, survived rigorous evaluation against dozens of contenders. See why experts are backing this one!
- - Rigorous evaluation cleared
- - Expert-backed selection
- - Mid Cap conviction pick
Financial Performance Overview
Over the past year, Ambalal Sarabhai Enterprises has delivered a return of -53.06%, contrasting with the Sensex’s positive return of 4.50% during the same period. This underperformance extends beyond the last year, with the stock also lagging behind the BSE500 index over the last three years and the recent three-month period.
Long-term growth metrics show that net sales have expanded at an annual rate of 7.00% over the past five years, indicating modest growth within the Pharmaceuticals & Biotechnology sector. However, the company’s return on capital employed (ROCE) averaged 4.55%, which is considered weak relative to industry standards.
Recent Quarterly and Annual Results
The company’s latest quarterly results for September 2025 reveal a profit before tax (PBT) of Rs. -1.66 crore, representing a decline of 548.6% compared to the previous four-quarter average. The net profit after tax (PAT) for the quarter stood at Rs. -0.56 crore, down 111.3% relative to the same benchmark. Operating cash flow for the year was recorded at Rs. -17.62 crore, marking the lowest level in recent periods.
Valuation and Shareholding
Despite the subdued financial performance, Ambalal Sarabhai Enterprises exhibits an attractive valuation profile with a ROCE of 1.5 and an enterprise value to capital employed ratio of 1.4. The stock is trading at a discount compared to the average historical valuations of its peers within the Pharmaceuticals & Biotechnology sector.
Interestingly, while the stock price has declined by over half in the last year, the company’s profits have risen by 24.8% during the same timeframe. This divergence is reflected in a price/earnings to growth (PEG) ratio of 0.5, suggesting that the market valuation does not fully align with recent profit trends.
Majority shareholding in Ambalal Sarabhai Enterprises is held by non-institutional investors, which may influence trading patterns and liquidity considerations.
Holding Ambalal Sarabhai Enterprises from Pharmaceuticals & Biotechnology? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Sector and Market Comparison
The Pharmaceuticals & Biotechnology sector has experienced mixed performance in recent months, with some companies maintaining steady growth while others face pricing pressures and regulatory scrutiny. Ambalal Sarabhai Enterprises’ stock price movement contrasts with the broader market’s resilience, as the Sensex continues to trade near its yearly highs supported by bullish moving averages.
This divergence highlights the challenges faced by the company relative to its sector peers and the overall market environment.
Summary of Key Metrics
To summarise, Ambalal Sarabhai Enterprises’ stock has reached a 52-week low of Rs.26.51, reflecting a significant decline from its high of Rs.68. The stock’s recent price action shows weakness across all major moving averages and a negative return over the past year. Financial results indicate subdued profitability and cash flow, while valuation metrics suggest the stock is trading at a discount relative to peers. The company’s profit growth over the last year contrasts with the stock’s price performance, underscoring a complex market assessment.
Limited Time Only! Upgrade now and get 1 Year of Stock of the week worth Rs. 14,999 for FREE. Don't miss out on this exclusive offer. Claim Your Free Year →
